Stimcell Energetics (STME) Operating Income Growth (3y) (2019 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | Stimcell Energetics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | 13.22% |
| Feb 29, 2024 | 30.21% |
| Nov 30, 2023 | 38.33% |
| Aug 31, 2023 | 36.00% |
| May 31, 2023 | 35.91% |
| Feb 28, 2023 | 25.33% |
| Nov 30, 2022 | 23.91% |
| Aug 31, 2022 | 15.26% |
| May 31, 2022 | 49.59% |
| Feb 28, 2022 | -38.80% |
| Nov 30, 2021 | -49.86% |
| Aug 31, 2021 | -43.79% |
| May 31, 2020 | 16.83% |
| Feb 29, 2020 | 4.71% |
| Nov 30, 2019 | -7.44% |
| Aug 31, 2019 | 2.50% |
| May 31, 2019 | -56.12% |
| Feb 28, 2019 | 37.19% |